CVS Group PLC
LSE:CVSG

Watchlist Manager
CVS Group PLC Logo
CVS Group PLC
LSE:CVSG
Watchlist
Price: 1 378 GBX -1.15%
Market Cap: £978.4m

CVS Group PLC
Investor Relations

CVS Group Plc is a holding company, which engages in the provision of veterinary services. The company is headquartered in Diss, Norfolk and currently employs 7,241 full-time employees. The company went IPO on 2007-10-10. The firm operates in the four business segments, namely Veterinary Practices, Laboratories, Crematoria and Online Retail Business. The company offers an integrated model with approximately 500 veterinary practices across its three territories, including eight specialist referral hospitals and 34 out-of-hours sites. Veterinary Practices provide specialist treatment for companion, equine and farm animals. The firm laboratories provide diagnostic services to CVS veterinary practices and third parties. The company offers a range of tests with the ability to tailor specific profiles to its customers' needs. Its crematoria provide pet cremation and clinical waste services to CVS practices and third-party practices, and cremations to animal owners. CVS online retail business, Animed Direct, sells prescription and nonprescription medicines, pet foods and a range of pet care products.

Show more
Loading
CVSG
FTSE All Share Index
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q2 2025
Call Date
Feb 27, 2025
AI Summary
Q2 2025

Revenue Growth: CVS Group delivered first-half revenue of £341.8 million, up 6.6% year-on-year, mainly driven by acquisitions in Australia.

Profitability: Adjusted EBITDA rose 4.5% to £67.4 million, though the adjusted EBITDA margin slipped by 0.4 percentage points to 19.7% due to inflationary pressures.

UK Headwinds: Weaker consumer demand and the ongoing CMA investigation in the UK led to flat like-for-like sales and a disciplined approach to UK investment.

Australian Expansion: The company completed five Australian acquisitions for £23.3 million and expects annualized revenue of around £55 million from practices acquired to date.

Cash Conversion & Leverage: Operating cash conversion was strong at 72%, and leverage remains comfortable at 1.66x, below the 2x target ceiling.

Cost Pressures: Wage inflation increased employment costs to 52.4% of revenue, with further UK cost increases expected from April 2025 due to legislation.

Guidance Affirmed: Management remains confident in delivering full-year results in line with market expectations and targets a return to organic revenue growth in H2 2025.

Tech & Client Focus: Significant investment in technology, including a new Animed Direct website and cloud-based systems, aims to enhance client experience.

Key Financials
Revenue
£341.8 million
Like-for-like Sales
-1.1%
Adjusted EBITDA
£67.4 million
Adjusted EBITDA Margin
19.7%
Free Cash Flow
£31.4 million
Operating Cash Conversion
72%
Leverage
1.66x
Net Bank Borrowings
£182.9 million
Adjusted EPS
40p
Employment Costs as % of Revenue
52.4%
Healthy Pet Club Membership
507,000
Number of Australian Practice Sites Acquired to Date
36
Expected Annualized Revenue from Australian Acquisitions
£55 million
Earnings Call Recording
Other Earnings Calls
2025

Management

Mr. Richard William Mark Fairman F.C.A.
CEO & Director
No Bio Available
Mr. Robin Jay Alfonso F.C.A.
CFO & Director
No Bio Available
Mr. Paul Higgs
Chief Veterinary Officer
No Bio Available
Charlotte Page
Group Financial Controller & Head of Investor Relations
No Bio Available
Mr. Scott Morrison
Group General Counsel & Company Secretary
No Bio Available
Ms. Helen Finney
Group HR Director
No Bio Available
Mr. Gordon Palmer
Head of IT
No Bio Available
James Cahill
MVB - Managing Director of CVS International
No Bio Available
Mr. Robert Dawson
Small Animal Director
No Bio Available
Ms. Elizabeth McLennan-Green
Small Animal Veterinary Director
No Bio Available

Contacts

Address
NORFOLK
Diss
C V S House, Owen Road
Contacts
+441379644288.0
www.cvsukltd.co.uk